How nitisinone tablets give hope to HT-1 and AKU patients. Now also available for free in India, Pakistan, Bangladesh and Sudan.
Medicine focus
-
August 02, 2023Read more »
-
July 14, 2023Read more »
Everything you need to know about Briumvi, the latest approved CD20 antibody for the treatment of multiple sclerosis.
-
June 26, 2023Read more »
All the safe and legal options to access Leqembi while it's waiting for its EU approval.
-
June 26, 2023Read more »
All you need to know about Leqembi, the latest approved Alzheimer's medicine.
-
June 16, 2023Read more »
Sotorasib vs Adagrasib: A side-by-side comparison of the latest Alzheimer's medicines.
-
Read more »
Anti-amyloid therapy for Alzheimer's, explained simply. What is it, how does it work, which one is approved, and how can you access it?
-
November 29, 2021Read more »
Paxlovid is an antiviral administered orally to patients who are ill with COVID-19 or have been exposed to the coronavirus SARS-CoV-2 and are at risk of developing severe illness. The manufacturer, pharmaceutical and biotechnology giant Pfizer, developed it to patients avoid severe illness which can lead to hospitalization and death. It is meant to be administered at the first sign of infection.
-
All about Lagevrio (molnupiravir): the first oral antiviral against COVID-19 | New COVID-19 Medicine
November 25, 2021Read more »Molnupiravir is an orally administered antiviral medication that inhibits the replication of certain RNA viruses, and is used to treat COVID-19.
-
June 10, 2021Read more »
Aduhelm (aducanumab) is a monthly intravenous infusion intended to slow cognitive decline by reducing amyloid beta plaques in the brain.
-
January 26, 2021Read more »
Ubrelvy (ubrogepant) is a calcitonin gene-related peptide (CGRP) receptor antagonist indicated for the acute treatment of migraine headaches with or without aura.
-
January 22, 2021Read more »
Tukysa (tucatinib) is a medication used in combination with trastuzumab and capecitabine for the treatment of adult patients with advanced, unresectable or metastatic HER2-positive breast cancer.
-
Read more »
Radicut (edaravone) and Radicava (edaravone) is a medication for the treatment of patients with amyotrophic lateral sclerosis (ALS) and acute ischaemic stroke.
-
January 22, 2021Read more »
Trodelvy (sacituzumab govitecan-hziy) is an immune targeted therapy used for the 3rd line treatment of patients with metastatic triple-negative breast cancer (mTNBC).
-
January 21, 2021Read more »
Tagrisso (osimertinib) is a kinase inhibitor (targeted therapy) medication.
-
January 21, 2021Read more »
Vyndaqel (tafamidis) is a medicine indicated for the treatment of transthyretin amyloidosis in patients with stage 1 symptomatic polyneuropathy to delay peripheral neurologic impairment.
-
January 21, 2021Read more »
Tibsovo (ivosidenib) is an IDH1 inhibitor (targeted therapy) medication.
-
January 19, 2021Read more »
Enhertu (fam-trastuzumab deruxtecan-nxki) is an antibody-drug conjugate targeted therapy.
-
December 09, 2020Read more »
Aimovig (erenumab) is a preventive migraine treatment that works by blocking the activity of calcitonin gene-related peptide, a molecule that is involved in migraine attacks
-
January 21, 2020Read more »
5 common questions about the supplement that may be useful for ALS, Parkinson's and Alzheimers.
